Eli Lilly (LLY) PT Raised to $1,327 at Morgan Stanley
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,208.12 +7.13%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn raised the price target on Eli Lilly (NYSE: LLY) to $1,327.00 (from $1,313.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Lilly's Jaypirca gets EU approval recommendation for CLL
- Incyte (INCY) PT Raised to $113 at UBS
- National Beverage (FIZZ) PT Lowered to $33 at UBS as Risk/Reward Skews to the Downside
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
